Published in PLoS Negl Trop Dis on June 06, 2013
Dendritic cells in dengue virus infection: targets of virus replication and mediators of immunity. Front Immunol (2014) 1.01
Sensing of immature particles produced by dengue virus infected cells induces an antiviral response by plasmacytoid dendritic cells. PLoS Pathog (2014) 0.86
Control of acute dengue virus infection by natural killer cells. Front Immunol (2014) 0.86
Therapeutic applications of TRAIL receptor agonists in cancer and beyond. Pharmacol Ther (2015) 0.80
Overcoming tumor immune evasion with an unique arbovirus. J Transl Med (2015) 0.75
Viability and functionality of Cryopreserved Peripheral Blood Mononuclear Cells in pediatric dengue. Clin Vaccine Immunol (2016) 0.75
Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement. Nat Commun (2017) 0.75
Primary dengue haemorrhagic fever in patients from northeast of Brazil is associated with high levels of interferon-β during acute phase. Mem Inst Oswaldo Cruz (2016) 0.75
Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases. Pharmacol Res Perspect (2017) 0.75
Dengue Virus Induces NK Cell Activation through TRAIL Expression during Infection. Mediators Inflamm (2017) 0.75
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science (2004) 16.26
The nature of the principal type 1 interferon-producing cells in human blood. Science (1999) 10.90
Plasmacytoid dendritic cells in immunity. Nat Immunol (2004) 9.11
The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell (2009) 7.88
Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science (1997) 6.82
The global emergence/resurgence of arboviral diseases as public health problems. Arch Med Res (2002) 6.77
Global spread and persistence of dengue. Annu Rev Microbiol (2008) 6.44
Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov (2007) 6.33
Dengue: an escalating problem. BMJ (2002) 6.09
Human skin Langerhans cells are targets of dengue virus infection. Nat Med (2000) 5.74
The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med (1997) 5.23
A structural perspective of the flavivirus life cycle. Nat Rev Microbiol (2005) 5.02
KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet (1997) 4.46
Molecular biology of flaviviruses. Adv Virus Res (2003) 4.39
Decisions about dendritic cells: past, present, and future. Annu Rev Immunol (2011) 4.26
Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons. J Virol (2000) 3.61
Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev (2009) 3.61
Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. Rev Infect Dis (1989) 3.53
Plasmacytoid dendritic cells: recent progress and open questions. Annu Rev Immunol (2011) 3.32
Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur J Immunol (2004) 3.25
Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections. J Virol (2010) 3.10
Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. J Virol (2004) 2.83
Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunol Rev (2010) 2.55
NS5 of dengue virus mediates STAT2 binding and degradation. J Virol (2009) 2.42
Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression. J Virol (2005) 2.37
Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients. Proc Natl Acad Sci U S A (2006) 2.08
Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS). Immunol Cell Biol (2006) 2.07
Usefulness and applicability of the revised dengue case classification by disease: multi-centre study in 18 countries. BMC Infect Dis (2011) 2.03
Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking. J Virol (2007) 2.03
HIV-1 gp120 inhibits TLR9-mediated activation and IFN-{alpha} secretion in plasmacytoid dendritic cells. Proc Natl Acad Sci U S A (2007) 2.01
Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells. J Immunol (2006) 1.99
Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. Clin Infect Dis (2006) 1.99
Regulation of TNF-related apoptosis-inducing ligand on primary CD4+ T cells by HIV-1: role of type I IFN-producing plasmacytoid dendritic cells. Proc Natl Acad Sci U S A (2005) 1.97
Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism. Virology (2001) 1.87
HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-alpha. Proc Natl Acad Sci U S A (2007) 1.85
Dengue virus NS5 inhibits interferon-alpha signaling by blocking signal transducer and activator of transcription 2 phosphorylation. J Infect Dis (2009) 1.83
DENV inhibits type I IFN production in infected cells by cleaving human STING. PLoS Pathog (2012) 1.80
The interaction of immunodeficiency viruses with dendritic cells. Curr Top Microbiol Immunol (2003) 1.79
Probability binning comparison: a metric for quantitating univariate distribution differences. Cytometry (2001) 1.65
Dengue virus type 2 antagonizes IFN-alpha but not IFN-gamma antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell. J Immunol (2005) 1.63
Flavivirus activation of plasmacytoid dendritic cells delineates key elements of TLR7 signaling beyond endosomal recognition. J Immunol (2006) 1.61
TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected patients and its in vitro production by antigen-presenting cells. Blood (2004) 1.60
High levels of interferon alpha in the sera of children with dengue virus infection. Am J Trop Med Hyg (1993) 1.56
Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever. Virology (2008) 1.54
TLR7: A new sensor of viral infection. Proc Natl Acad Sci U S A (2004) 1.49
Markers of dengue disease severity. Curr Top Microbiol Immunol (2010) 1.46
Dengue virus targets the adaptor protein MITA to subvert host innate immunity. PLoS Pathog (2012) 1.44
Retrospective study on dengue fatal cases. Clin Neuropathol (1997) 1.43
Dengue virus inhibits the production of type I interferon in primary human dendritic cells. J Virol (2010) 1.42
Differential effects of dengue virus on infected and bystander dendritic cells. J Virol (2005) 1.33
HBsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells. Mol Immunol (2009) 1.31
How TRAIL kills cancer cells, but not normal cells. Science (1997) 1.29
The yin and yang of viruses and interferons. Trends Immunol (2012) 1.25
Dengue-virus-infected dendritic cells trigger vascular leakage through metalloproteinase overproduction. EMBO Rep (2006) 1.24
A blunted blood plasmacytoid dendritic cell response to an acute systemic viral infection is associated with increased disease severity. J Immunol (2003) 1.22
NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease. Clin Exp Immunol (2006) 1.22
Different clinical and laboratory manifestations between dengue haemorrhagic fever and dengue fever with bleeding tendency. Trans R Soc Trop Med Hyg (2007) 1.21
Functional characterization of ex vivo blood myeloid and plasmacytoid dendritic cells after infection with dengue virus. Virology (2008) 1.20
TRAIL is a novel antiviral protein against dengue virus. J Virol (2007) 1.17
Plasmacytoid dendritic cells reduce HIV production in elite controllers. J Virol (2012) 1.09
Viral replication and paracrine effects result in distinct, functional responses of dendritic cells following infection with dengue 2 virus. J Leukoc Biol (2008) 1.09
Gene expression profiling of dengue infected human primary cells identifies secreted mediators in vivo. J Med Virol (2009) 1.08
Plasma leakage in dengue haemorrhagic fever. Thromb Haemost (2009) 1.08
Biologic properties of dengue viruses following serial passage in primary dog kidney cells: studies at the University of Hawaii. Am J Trop Med Hyg (2003) 1.08
Plasmacytoid dendritic cells (pDCs) from HIV controllers produce interferon-α and differentiate into functional killer pDCs under HIV activation. J Infect Dis (2012) 1.04
Inducible nitric oxide synthase (iNOS) expression in monocytes during acute Dengue Fever in patients and during in vitro infection. BMC Infect Dis (2005) 1.03
Regulation of soluble and surface-bound TRAIL in human T cells, B cells, and monocytes. Cytokine (2003) 1.03
Endothelial cells elicit immune-enhancing responses to dengue virus infection. J Virol (2012) 1.00
Free HTLV-1 induces TLR7-dependent innate immune response and TRAIL relocalization in killer plasmacytoid dendritic cells. Blood (2009) 0.99
How flaviviruses activate and suppress the interferon response. Viruses (2010) 0.92
Decreased dengue replication and an increased anti-viral humoral response with the use of combined Toll-like receptor 3 and 7/8 agonists in macaques. PLoS One (2011) 0.91
Engagement of BDCA-2 blocks TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells. Immunobiology (2009) 0.91
Dengue-2 and yellow fever 17DD viruses infect human dendritic cells, resulting in an induction of activation markers, cytokines and chemokines and secretion of different TNF-α and IFN-α profiles. Mem Inst Oswaldo Cruz (2011) 0.90
The TRAIL to viral pathogenesis: the good, the bad and the ugly. Curr Mol Med (2009) 0.89
Dengue-2 infection and the induction of apoptosis in human primary monocytes. Mem Inst Oswaldo Cruz (2009) 0.89
Clinical analysis of dendritic cell subsets: the dendritogram. Methods Mol Biol (2008) 0.86
Decreased peripheral dendritic cell numbers in dengue virus infection. J Clin Immunol (2011) 0.80
An in vitro model for dengue virus infection that exhibits human monocyte infection, multiple cytokine production and dexamethasone immunomodulation. Mem Inst Oswaldo Cruz (2007) 0.80
Tissue factor expression on monocytes from patients with severe dengue fever. Blood Cells Mol Dis (2010) 0.76
Effect of interferons on dengue virus multiplication in cultured monocytes/macrophages. Biken J (1984) 0.76
Two Chikungunya isolates from the outbreak of La Reunion (Indian Ocean) exhibit different patterns of infection in the mosquito, Aedes albopictus. PLoS One (2007) 4.95
A nonsense mutation in the gene encoding 2'-5'-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice. Proc Natl Acad Sci U S A (2002) 2.65
HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. Blood (2006) 2.58
Regulated on activation, normal T cell expressed and secreted (RANTES) antagonist (Met-RANTES) controls the early phase of Trypanosoma cruzi-elicited myocarditis. Circulation (2004) 1.86
HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-alpha. Proc Natl Acad Sci U S A (2007) 1.85
Dengue virus type 3, Brazil, 2002. Emerg Infect Dis (2005) 1.64
The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities. J Interferon Cytokine Res (2010) 1.59
West Nile virus and its emergence in the United States of America. Vet Res (2010) 1.56
Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells. Blood (2004) 1.34
[Paracoccidioidomycosis: a clinical and epidemiological study of 422 cases observed in Mato Grosso do Sul]. Rev Soc Bras Med Trop (2003) 1.32
NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells. J Immunol (2009) 1.27
New insights on the neuropathology of West Nile virus. FEMS Microbiol Lett (2004) 1.20
Protective antiviral immunity conferred by a nonintegrative lentiviral vector-based vaccine. PLoS One (2008) 1.16
A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus. J Gene Med (2006) 1.14
Plasmacytoid dendritic cells (pDCs) from HIV controllers produce interferon-α and differentiate into functional killer pDCs under HIV activation. J Infect Dis (2012) 1.04
Proinflammatory environment dictates the IL-17-producing capacity of human invariant NKT cells. J Immunol (2011) 1.04
HIV/AIDS-associated visceral leishmaniasis in patients from an endemic area in Central-west Brazil. Mem Inst Oswaldo Cruz (2010) 1.03
TNF/TNFR1 signaling up-regulates CCR5 expression by CD8+ T lymphocytes and promotes heart tissue damage during Trypanosoma cruzi infection: beneficial effects of TNF-alpha blockade. Mem Inst Oswaldo Cruz (2008) 1.03
Paracoccidioidomycosis in patients with human immunodeficiency virus: review of 12 cases observed in an endemic region in Brazil. J Infect (2005) 1.01
Free HTLV-1 induces TLR7-dependent innate immune response and TRAIL relocalization in killer plasmacytoid dendritic cells. Blood (2009) 0.99
Dermal-type macrophages expressing CD209/DC-SIGN show inherent resistance to dengue virus growth. PLoS Negl Trop Dis (2008) 0.97
Innate pro-B-cell progenitors protect against type 1 diabetes by regulating autoimmune effector T cells. Proc Natl Acad Sci U S A (2013) 0.96
Compliance to antiretroviral medication as reported by AIDS patients assisted at the University Hospital of the Federal University of Mato Grosso do Sul. Braz J Infect Dis (2002) 0.95
Clinical and hepatic evaluation in adult dengue patients: a prospective two-month cohort study. Rev Soc Bras Med Trop (2012) 0.94
Validating plastic scintillation detectors for photon dosimetry in the radiologic energy range. Med Phys (2012) 0.93
Sensitivity and specificity of polymerase chain reaction in Giemsa-stained slides for diagnosis of visceral leishmaniasis in children. Mem Inst Oswaldo Cruz (2007) 0.92
Rapamycin combined with TGF-β converts human invariant NKT cells into suppressive Foxp3+ regulatory cells. J Immunol (2011) 0.91
Dengue-2 and yellow fever 17DD viruses infect human dendritic cells, resulting in an induction of activation markers, cytokines and chemokines and secretion of different TNF-α and IFN-α profiles. Mem Inst Oswaldo Cruz (2011) 0.90
DNA vaccines expressing retrovirus-like particles are efficient immunogens to induce neutralizing antibodies. Vaccine (2009) 0.90
Regulation of inflammatory chemokine receptors on blood T cells associated to the circulating versus liver chemokines in dengue fever. PLoS One (2012) 0.88
Profile of circulating levels of IL-1Ra, CXCL10/IP-10, CCL4/MIP-1β and CCL2/MCP-1 in dengue fever and parvovirosis. Mem Inst Oswaldo Cruz (2012) 0.88
Three-dimensional microscopy characterization of death receptor 5 expression by over-activated human primary CD4+ T cells and apoptosis. PLoS One (2012) 0.86
Apoptotic mediators in patients with severe and non-severe dengue from Brazil. J Med Virol (2013) 0.81
An in vitro model for dengue virus infection that exhibits human monocyte infection, multiple cytokine production and dexamethasone immunomodulation. Mem Inst Oswaldo Cruz (2007) 0.80
Sub-second high dose rate brachytherapy Monte Carlo dose calculations with bGPUMCD. Med Phys (2012) 0.80
IFN-α and TRAIL: a double edge sword in HIV-1 disease? Exp Cell Res (2012) 0.79
CCL22-producing CD8α- myeloid dendritic cells mediate regulatory T cell recruitment in response to G-CSF treatment. J Immunol (2013) 0.79
RasV12 induces Survivin/AuroraB pathway conferring tumor cell apoptosis resistance. Cell Signal (2010) 0.78
Characteristics of plasmacytoid dendritic cell and CD4+ T cell in HIV elite controllers. Clin Dev Immunol (2012) 0.77
Dyslipidaemia associated with the highly active antiretroviral therapy in AIDS patient: reversion after switching (stavudine to tenofovir and lopinavir/ritonavir to atazanavir/ritonavir). Braz J Infect Dis (2007) 0.77
TRAIL protein localization in human primary T cells by 3D microscopy using 3D interactive surface plot: a new method to visualize plasma membrane. J Immunol Methods (2012) 0.77
CD4 and Tumor Necrosis Factor-Related Apoptosis Ligand (TRAIL) localization in HIV-stimulated plasmacytoid dendritic cells by three-dimensional microscopy. AIDS Res Hum Retroviruses (2014) 0.77
Tissue factor expression on monocytes from patients with severe dengue fever. Blood Cells Mol Dis (2010) 0.76
Neuroparacoccidioidomycosis: analysis of 13 cases observed in an endemic area in Brazil. Trans R Soc Trop Med Hyg (2006) 0.76
Molecular polymorphism of native gonadotropin-releasing hormone (GnRH) is restricted to mammalian GnRH and [hydroxyproline9] GnRH in the developing rat brain. Neuroendocrinology (2005) 0.75
Antiviral and Immunomodulatory Effects of Norantea brasiliensis Choisy on Dengue Virus-2. Intervirology (2017) 0.75
New suppressor technology improves trace level anion analysis with carbonate-hydrogencarbonate mobile phases. J Chromatogr A (2002) 0.75
Synthesis of 3'-fluoro-tRNA analogues for exploring non-ribosomal peptide synthesis in bacteria. Chembiochem (2015) 0.75
[Liver involvement in patients with dengue hemorrhagic fever: a rare phenomenon?]. Rev Soc Bras Med Trop (2007) 0.75